Psoriasis Clinical Trial
Enrolling Now

Clinics: Cannock, Manchester and Teesside

Therapy Area: Plaque Psoriasis

Gender and Age: Males & Females aged 18 and over

Reimbursement: Reasonable travel expenses or transport to the clinic will be provided.

About The Research...

MAC is currently conducting a trial to test a new oral treatment for moderate to severe plaque psoriasis. Plaque psoriasis is a chronic inflammatory skin disorder and is the most common form of the condition, affecting up to 3% of the general population. It is characterised primarily by red scaly plaques that normally appear on elbows, knees, scalp and lower back, but can appear anywhere on the body.

The purpose of this trial is to measure how safe and effective the trial medication is in treating participants with psoriasis.

Criteria:

Key Inclusion Criteria:

  • Men and women aged ≥18 years
  • Diagnosis of stable plaque psoriasis ≥6 months

Key Exclusion Criteria:

  • Has non-plaque psoriasis
  • History of serious bacterial, fungal, or viral infections requiring hospitalization within the past 3 months or any infection requiring antibiotic treatment within the past 15 days

 

Other eligibility criteria will apply. Please contact MAC for more information.

Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the patient’s treating physician.

Key Inclusion Criteria

  •  

Key Exclusion Criteria

  •  


MAC Clinical Research is currently conducting a trial to test a new potential treatment for moderate to severe plaque psoriasis.

If you would like more information, please fill in the form below and we will be in touch…

Alternatively, please call our recruitment team on freephone 0800 633 5507.

  • Please select the condition that applies to you. We can collect more information about your health when we contact you.
  • (You can enter any supporting information here)
Data Privacy Statement

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on email
Email